Safety of Monitoring During Use of Ozempic in People with Diabetes: A CDM Pilot Project

Safety of Monitoring During Use of Ozempic in People with Diabetes: A CDM Pilot Project

Safety of Monitoring During Use of Ozempic in People with Diabetes: A CDM Pilot Project

OS0005_CDM

Overview

Background
  • There is a need for real-world safety outcome monitoring of Ozempic in people with diabetes as its use increases in Canada.
Objectives
  • The aim of this pilot project is to conduct a cohort study in 4 Canadian provinces to demonstrate the feasibility of replicating a US FDA Sentinel TreeScan signal-detection analysis using Ozempic as the case study.

Manuscripts

Presentations

Project Team

Project Lead
Michael Paterson MSc
Methods Lead
Robert W. Platt PhD
Content Expert
Baiju Shah MD, PhD
Project Manager
Carolina Moriello MSc
Site Investigator
Donica Janzen PhD
Saskatchewan
Site Investigator
Michael Paterson MSc
Ontario
Site Investigator
Sherif Eltonsy MSc, PhD
Manitoba
Site Investigator
Colin R. Dormuth ScD
British Columbia
Analyst
Xinya Lu PhD
Saskatchewan
Analyst
Fangyun Wu MSc
Ontario
Analyst
Matthew Dahl BSc
Manitoba
Analyst
Sean Burnett MA, Econ
British Columbia